Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bipolar Episodes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT01092221
What this trial is testing

Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode

Who this might be right for
Mania
Sheba Medical Center 180
Testing effectiveness (Phase 2)Study completedNCT06605599
What this trial is testing

Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

Who this might be right for
Bipolar I DisorderBipolar II Disorder
AbbVie 161
Large-scale testing (Phase 3)Study completedNCT00249236
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder

Who this might be right for
Bipolar DisorderManic Episode
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 291
Large-scale testing (Phase 3)Ended earlyNCT02075047
What this trial is testing

Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 171
Not applicableStudy completedNCT00543088
What this trial is testing

Effectiveness of Anti-Psychotic in GPs Setting

Who this might be right for
SchizophreniaBipolar Disorder
AstraZeneca 250
Large-scale testing (Phase 3)Study completedNCT01396291
What this trial is testing

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

Who this might be right for
Bipolar 1 Disorder
Forest Laboratories 561
Post-approval studies (Phase 4)Study completedNCT00397020
What this trial is testing

Naturalistic Study, Comparison of Divalproex Extended Release (ER) and Quetiapine for Adults With Acute Mania or Mixed Episodes

Who this might be right for
Bipolar Disorder
University of California, San Diego 30
Not applicableLooking for participantsNCT07462637
What this trial is testing

Signature Response to Light Therapy in Unipolar and Bipolar Major Depressive Episode (MDE)

Who this might be right for
Major Depressive Episode
Assistance Publique - Hôpitaux de Paris 173
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Large-scale testing (Phase 3)Study completedNCT02600494
What this trial is testing

Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression

Who this might be right for
Bipolar Depression
Intra-Cellular Therapies, Inc. 554
Large-scale testing (Phase 3)Study completedNCT01977300
What this trial is testing

Atypical Antipsychotics for Continuation and Maintenance Treatment After an Acute Manic Episode

Who this might be right for
Bipolar I Disorder
University of British Columbia 159
Testing effectiveness (Phase 2)Ended earlyNCT01824602
What this trial is testing

Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder

Who this might be right for
BIPOLAR I DISORDER
Bial - Portela C S.A. 38